Gagnon Advisors, LLC Celcuity Inc. Transaction History

Gagnon Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$5.35 - $10.11 $34,882 - $65,917	-6,520 Reduced 3.47%	181,353 $1.65 Million
Q2 2021 Jul 28, 2021	SELL	$14.25 - $30.93 $572,308 - $1.24 Million	-40,162 Reduced 17.61%	187,873 $4.51 Million
Q1 2021 May 14, 2021	BUY	$10.43 - $17.8 $899,316 - $1.53 Million	86,224 Added 60.8%	228,035 $3.27 Million
Q2 2020 Aug 13, 2020	BUY	$4.42 - $11.04 $40,593 - $101,391	9,184 Added 6.92%	141,811 $983,000
Q2 2018 Aug 09, 2018	BUY	$16.13 - $26.99 $34,147 - $57,137	2,117 Added 1.62%	132,627 $3.29 Million
Q4 2017 Feb 13, 2018	BUY	$12.12 - $21.65 $7,102 - $12,686	586 Added 0.45%	130,510 $2.47 Million
Q3 2017 Nov 14, 2017	BUY	$11.94 - $14.29 $1.55 Million - $1.86 Million	129,924	129,924 $1.59 Million

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $190M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Gagnon Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Gagnon Advisors, LLC with notifications on news.